Nutritional Strategies for Battling Obesity-Linked Liver Disease: the Role of Medical Nutritional Therapy in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) Management

Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes

Younossi, Z. M., Koenig, A. B., Abdelatif, D., Fazel, Y., Henry, L., & Wymer, M. (2016) · Hepatology · doi:10.1002/hep.28431 · Cited by 10,781 · see citing works

The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases

Chalasani, N., Younossi, Z., Lavine, J. E., Charlton, M., Cusi, K., Rinella, M., Harrison, S. A., Brunt, E. M., & Sanyal, A. J. (2018) · Hepatology · doi:10.1002/hep.29367 · Cited by 7,239 · see citing works

A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement

Eslam, M., Newsome, P. N., Sarin, S. K., Anstee, Q. M., Targher, G., Romero-Gomez, M., Zelber-Sagi, S., Wai-Sun Wong, V., Dufour, J.-F., Schattenberg, J. M., et al. (2020) · Journal of Hepatology · doi:10.1016/j.jhep.2020.03.039 · Cited by 4,472 · see citing works

Obesity and cardiovascular disease: a scientific statement from the American Heart Association

Powell-Wiley, T. M., Poirier, P., Burke, L. E., Després, J.-P., Gordon-Larsen, P., Lavie, C. J., Lear, S. A., Ndumele, C. E., Neeland, I. J., Sanders, P., et al. (2021) · Circulation · doi:10.1161/cir.0000000000000973 · Cited by 3,691 · see citing works

MAFLD: a consensus-driven proposed nomenclature for metabolic associated fatty liver disease

Eslam, M., Sanyal, A. J., George, J., Sanyal, A., Neuschwander-Tetri, B., Tiribelli, C., Kleiner, D. E., Brunt, E., Bugianesi, E., Yki-Järvinen, H., et al. (2020) · Gastroenterology · doi:10.1053/j.gastro.2019.11.312 · Cited by 3,286 · see citing works

Liver Fibrosis, but No Other Histologic Features, Is Associated With Long-term Outcomes of Patients With Nonalcoholic Fatty Liver Disease

Angulo, P., Kleiner, D. E., Dam-Larsen, S., Adams, L. A., Bjornsson, E. S., Charatcharoenwitthaya, P., Mills, P. R., Keach, J. C., Lafferty, H. D., Stahler, A., et al. (2015) · Gastroenterology · doi:10.1053/j.gastro.2015.04.043 · Cited by 2,987 · see citing works

AASLD practice guidance on the clinical assessment and management of nonalcoholic fatty liver disease

Rinella, M. E., Neuschwander-Tetri, B. A., Siddiqui, M. S., Abdelmalek, M. F., Caldwell, S., Barb, D., Kleiner, D. E., & Loomba, R. (2023) · Hepatology · doi:10.1097/hep.0000000000000323 · Cited by 2,667 · see citing works

Pathophysiology of human visceral obesity: an update

Tchernof, A., & Després, J.-P. (2013) · Physiological Reviews · doi:10.1152/physrev.00033.2011 · Cited by 2,583 · see citing works

Weight loss through lifestyle modification significantly reduces features of nonalcoholic steatohepatitis

Vilar-Gomez, E., Martinez-Perez, Y., Calzadilla-Bertot, L., Torres-Gonzalez, A., Gra-Oramas, B., Gonzalez-Fabian, L., Friedman, S. L., Diago, M., & Romero-Gomez, M. (2015) · Gastroenterology · doi:10.1053/j.gastro.2015.04.005 · Cited by 2,492 · see citing works

The gut-liver axis in liver disease: Pathophysiological basis for therapy

Albillos, A., de Gottardi, A., & Rescigno, M. (2020) · Journal of Hepatology · doi:10.1016/j.jhep.2019.10.003 · Cited by 2,166 · see citing works

Molecular and cellular mechanisms of liver fibrosis and its regression

Kisseleva, T., & Brenner, D. (2021) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-020-00372-7 · Cited by 2,024 · see citing works

Mechanisms and disease consequences of nonalcoholic fatty liver disease

Loomba, R., Friedman, S. L., & Shulman, G. I. (2021) · Cell · doi:10.1016/j.cell.2021.04.015 · Cited by 2,002 · see citing works

Adipose tissue inflammation and metabolic dysfunction in obesity

Kawai, T., Autieri, M. V., & Scalia, R. (2021) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00379.2020 · Cited by 1,947 · see citing works

Fibrosis Progression in Nonalcoholic Fatty Liver vs Nonalcoholic Steatohepatitis: A Systematic Review and Meta-analysis of Paired-Biopsy Studies

Singh, S., Allen, A. M., Wang, Z., Prokop, L. J., Murad, M. H., & Loomba, R. (2015) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2014.04.014 · Cited by 1,748 · see citing works

The Healthy Eating Index

Kennedy, E., Ohls, J. C., Carlson, S. J., & Fleming, K. E. (1995) · Journal of the American Dietetic Association · doi:10.1016/s0002-8223(95)00300-2 · Cited by 1,626 · see citing works

Randomized controlled trial testing the effects of weight loss on nonalcoholic steatohepatitis

Promrat, K., Kleiner, D. E., Niemeier, H. M., Jackvony, E., Kearns, M., Wands, J. R., Fava, J. L., & Wing, R. R. (2010) · Hepatology · doi:10.1002/hep.23276 · Cited by 1,330 · see citing works

Skeletal muscle lipid content and insulin resistance: evidence for a paradox in endurance-trained athletes

Goodpaster, B. H. (2001) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.86.12.5755 · Cited by 1,194 · see citing works

Dietary fiber and body weight

Slavin, J. L. (2005) · Nutrition · doi:10.1016/j.nut.2004.08.018 · Cited by 1,091 · see citing works

Dietary Fiber and Weight Regulation

Howarth, N. C., Saltzman, E. J., & Roberts, S. B. (2009) · Nutrition Reviews · doi:10.1111/j.1753-4887.2001.tb07001.x · Cited by 1,053 · see citing works

American Association of Clinical Endocrinology Clinical Practice Guideline for the Diagnosis and Management of Nonalcoholic Fatty Liver Disease in Primary Care and Endocrinology Clinical Settings

Cusi, K., Isaacs, S., Barb, D., Basu, R., Caprio, S., Garvey, W. T., Kashyap, S., Mechanick, J. I., Mouzaki, M., Nadolsky, K., et al. (2022) · Endocrine Practice · doi:10.1016/j.eprac.2022.03.010 · Cited by 1,021 · see citing works

Selective versus Total Insulin Resistance: A Pathogenic Paradox

Brown, M. S., & Goldstein, J. L. (2008) · Cell Metabolism · doi:10.1016/j.cmet.2007.12.009 · Cited by 959 · see citing works

Impact of Healthy Lifestyle Factors on Life Expectancies in the US Population

Li, Y., Pan, A., Wang, D. D., Liu, X., Dhana, K., Franco, O. H., Kaptoge, S., Di Angelantonio, E., Stampfer, M., Willett, W. C., et al. (2018) · Circulation · doi:10.1161/circulationaha.117.032047 · Cited by 927 · see citing works

Global prevalence, incidence, and outcomes of non-obese or lean non-alcoholic fatty liver disease: a systematic review and meta-analysis

Ye, Q., Zou, B., Yeo, Y. H., Li, J., Huang, D. Q., Wu, Y., Yang, H., Liu, C., Kam, L. Y., Tan, X. X. E., et al. (2020) · The Lancet Gastroenterology & Hepatology · doi:10.1016/s2468-1253(20)30077-7 · Cited by 925 · see citing works

Effects of Moderate and Subsequent Progressive Weight Loss on Metabolic Function and Adipose Tissue Biology in Humans with Obesity

Magkos, F., Fraterrigo, G., Yoshino, J., Luecking, C., Kirbach, K., Kelly, S. C., de las Fuentes, L., He, S., Okunade, A. L., Patterson, B. W., et al. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2016.02.005 · Cited by 886 · see citing works

A multisociety Delphi consensus statement on new fatty liver disease nomenclature

Rinella, M. E., Lazarus, J. V., Ratziu, V., Francque, S. M., Sanyal, A. J., Kanwal, F., Romero, D., Abdelmalek, M. F., Anstee, Q. M., Arab, J. P., et al. (2024) · Annals of Hepatology · doi:10.1016/j.aohep.2023.101133 · Cited by 844 · see citing works

Obesity and type 2 diabetes mellitus: connections in epidemiology, pathogenesis, and treatments

Ruze, R., Liu, T., Zou, X., Song, J., Chen, Y., Xu, R., Yin, X., & Xu, Q. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1161521 · Cited by 799 · see citing works

Metabolic dysfunction-associated steatotic liver disease (MASLD): a state-of-the-art review

Chan, W.-K., Chuah, K.-H., Rajaram, R. B., Lim, L.-L., Ratnasingam, J., & Vethakkan, S. R. (2023) · Journal of Obesity & Metabolic Syndrome · doi:10.7570/jomes23052 · Cited by 776 · see citing works

Global prevalence of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in the overweight and obese population: a systematic review and meta-analysis

Quek, J., Chan, K. E., Wong, Z. Y., Tan, C., Tan, B., Lim, W. H., Tan, D. J. H., Tang, A. S. P., Tay, P., Xiao, J., et al. (2023) · The Lancet Gastroenterology & Hepatology · doi:10.1016/s2468-1253(22)00317-x · Cited by 749 · see citing works

EASL–EASD–EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease

European Association for the Study of the Liver (EASL), European Association for the Study of Diabetes (EASD), & European Association for the Study of Obesity (EASO) (2016) · Diabetologia · doi:10.1007/s00125-016-3902-y · Cited by 685 · see citing works

Definitions and potential health benefits of the Mediterranean diet: views from experts around the world

Trichopoulou, A., Martínez‐González, M. Á., Tong, T. Y. N., Forouhi, N. G., Khandelwal, S., Prabhakaran, D., Mozaffarian, D., & de Lorgeril, M. (2014) · BMC Medicine · doi:10.1186/1741-7015-12-112 · Cited by 667 · see citing works

Prevalence of obesity and diabetes in patients with cryptogenic cirrhosis: A case-control study

Poonawala, A., Nair, S. P., & Thuluvath, P. J. (2000) · Hepatology · doi:10.1053/jhep.2000.17894 · Cited by 566 · see citing works

Guidelines for the assessment and management of non‐alcoholic fatty liver disease in the Asia–Pacific region: Executive summary

Farrell, G. C., Chitturi, S., Lau, G. K. K., Sollano, J. D., & NAFLD, F. T. A. W. P. O. (2007) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2007.05002.x · Cited by 518 · see citing works

AGA Clinical Practice Update on Lifestyle Modification Using Diet and Exercise to Achieve Weight Loss in the Management of Nonalcoholic Fatty Liver Disease: Expert Review

Younossi, Z. M., Corey, K. E., & Lim, J. K. (2020) · Gastroenterology · doi:10.1053/j.gastro.2020.11.051 · Cited by 503 · see citing works

The Carbohydrate-Insulin Model of Obesity

Ludwig, D. S., & Ebbeling, C. B. (2018) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2018.2933 · Cited by 452 · see citing works

Silybin and silymarin - new effects and applications

Křen, V., & Walterová, D. (2005) · Biomedical Papers · doi:10.5507/bp.2005.002 · Cited by 448 · see citing works

Epidemiological modifiers of non-alcoholic fatty liver disease: Focus on high-risk groups

Lonardo, A., Bellentani, S., Argo, C. K., Ballestri, S., Byrne, C. D., Caldwell, S. H., Cortez‐Pinto, H., Grieco, A., Machado, M. V., Miele, L., et al. (2015) · Digestive and Liver Disease · doi:10.1016/j.dld.2015.08.004 · Cited by 444 · see citing works

Dietary fat and carbohydrates differentially alter insulin sensitivity during caloric restriction

Kirk, E., Reeds, D. N., Finck, B. N., Mayurranjan, M. S., Patterson, B. W., & Klein, S. (2009) · Gastroenterology · doi:10.1053/j.gastro.2009.01.048 · Cited by 440 · see citing works

Adipose Tissue-Liver Cross Talk in the Control of Whole-Body Metabolism: Implications in Nonalcoholic Fatty Liver Disease

Azzu, V., Vacca, M., Virtue, S., Allison, M., & Vidal-Puig, A. (2020) · Gastroenterology · doi:10.1053/j.gastro.2019.12.054 · Cited by 369 · see citing works

Nutritional Wheat Amylase-Trypsin Inhibitors Promote Intestinal Inflammation via Activation of Myeloid Cells

Zevallos, V. F., Raker, V., Tenzer, S., Calvente, C. J., Ashfaq–Khan, M., Rüssel, N., Pickert, G., Schild, H., Steinbrink, K., & Schuppan, D. (2016) · Gastroenterology · doi:10.1053/j.gastro.2016.12.006 · Cited by 325 · see citing works

Molecular aspects of fructose metabolism and metabolic disease

Herman, M. A., & Birnbaum, M. J. (2021) · Cell Metabolism · doi:10.1016/j.cmet.2021.09.010 · Cited by 298 · see citing works

Metabolic and histological implications of intrahepatic triglyceride content in nonalcoholic fatty liver disease

Bril, F., Barb, D., Portillo-Sánchez, P., Biernacki, D., Lomonaco, R., Suman, A., Weber, M. H., Budd, J. T., Lupi, M. E., & Cusi, K. J. (2016) · Hepatology · doi:10.1002/hep.28985 · Cited by 291 · see citing works

European Guidelines for Obesity Management in Adults with a Very Low-Calorie Ketogenic Diet: A Systematic Review and Meta-Analysis

Muscogiuri, G., El Ghoch, M., Colao, A., Hassapidou, M., Yumuk, V., Busetto, L., & Obesity Management Task Force (OMTF) of the European Association for the Study of Obesity (EASO) (2021) · Obesity Facts · doi:10.1159/000515381 · Cited by 289 · see citing works

Very-Low-Calorie Ketogenic Diet (VLCKD) in the Management of Metabolic Diseases: Systematic Review and Consensus Statement from the Italian Society of Endocrinology (SIE)

Caprio, M., Infante, M., Moriconi, E., Armani, A., Fabbri, A., Mantovani, G., Mariani, S., Lubrano, C., Poggiogalle, E., Migliaccio, S., et al. (2019) · Journal of Endocrinological Investigation · doi:10.1007/s40618-019-01061-2 · Cited by 283 · see citing works

The Natural History of Nonalcoholic Fatty Liver Disease—An Evolving View

Lindenmeyer, C. C., & McCullough, A. J. (2017) · Clinics in Liver Disease · doi:10.1016/j.cld.2017.08.003 · Cited by 271 · see citing works

Association of Weight Loss Interventions With Changes in Biomarkers of Nonalcoholic Fatty Liver Disease

Koutoukidis, D. A., Astbury, N. M., Tudor, K., Morris, E. M., Henry, J. A., Noreik, M., Jebb, S. A., & Aveyard, P. N. (2019) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2019.2248 · Cited by 270 · see citing works

Anti-Inflammatory Nutrients and Obesity-Associated Metabolic-Inflammation: State of the Art and Future Direction

Grosso, G., Laudisio, D., Frias-Toral, E., Barrea, L., Muscogiuri, G., Savastano, S., & Colao, A. (2022) · Nutrients · doi:10.3390/nu14061137 · Cited by 255 · see citing works

Fructose and hepatic insulin resistance

Softic, S., Stanhope, K. L., Boucher, J., Divanovic, S., Lanaspa, M. A., Johnson, R. J., & Kahn, C. R. (2020) · Critical Reviews in Clinical Laboratory Sciences · doi:10.1080/10408363.2019.1711360 · Cited by 255 · see citing works

Effects of diet versus gastric bypass on metabolic function in diabetes

Yoshino, M., Kayser, B. D., Yoshino, J., Stein, R. I., Reeds, D., Eagon, J. C., Eckhouse, S. R., Watrous, J. D., Jain, M., Knight, R., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2003697 · Cited by 246 · see citing works

The role of nutrition in non‐alcoholic fatty liver disease: Pathophysiology and management

Berná, G., & Romero‐Gómez, M. (2020) · Liver International · doi:10.1111/liv.14360 · Cited by 235 · see citing works

Ad libitum mediterranean and low-fat diets both significantly reduce hepatic steatosis: a randomized controlled trial

Properzi, C., O'Sullivan, T. A., Sherriff, J. L., Ching, H. L., Jeffrey, G. P., Buckley, R. F., Tibballs, J., MacQuillan, G. C., Garas, G., & Adams, L. A. (2018) · Hepatology · doi:10.1002/hep.30076 · Cited by 227 · see citing works

Dietary fiber in the prevention of obesity and obesity-related chronic diseases: From epidemiological evidence to potential molecular mechanisms

Waddell, I. S., & Orfila, C. (2023) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2022.2061909 · Cited by 211 · see citing works

Mediterranean Diet and Obesity-related Disorders: What is the Evidence?

Muscogiuri, G., Verde, L., Sulu, C., Katsiki, N., Hassapidou, M., Frias-Toral, E., Cucalón, G., Pazderska, A., Yumuk, V. D., Colao, A., et al. (2022) · Current Obesity Reports · doi:10.1007/s13679-022-00481-1 · Cited by 207 · see citing works

Weight loss and risk reduction of obesity-related outcomes in 0·5 million people: evidence from a UK primary care database

Haase, C. L., Lopes, S., Olsen, A. H., Satylganova, A., Schnecke, V., & McEwan, P. (2021) · International Journal of Obesity · doi:10.1038/s41366-021-00788-4 · Cited by 199 · see citing works

Dietary fiber and satiety: the effects of oats on satiety

Rebello, C. J., O’Neil, C. E., & Greenway, F. L. (2016) · Nutrition Reviews · doi:10.1093/nutrit/nuv063 · Cited by 188 · see citing works

The effect of the magnitude of weight loss on non-alcoholic fatty liver disease: a systematic review and meta-analysis

Koutoukidis, D. A., Koshiaris, C., Henry, J. A., Noreik, M., Morris, E., Manoharan, I., Tudor, K., Bodenham, E., Dunnigan, A., Jebb, S. A., et al. (2021) · Metabolism · doi:10.1016/j.metabol.2020.154455 · Cited by 186 · see citing works

Nonalcoholic fatty liver disease

Schaffner, F., & Thaler, H. (2020) · Nursing · doi:10.1097/01.nurse.0000656496.00204.01 · Cited by 180 · see citing works

The Management of Very Low-Calorie Ketogenic Diet in Obesity Outpatient Clinic: A Practical Guide

Muscogiuri, G., Barrea, L., Laudisio, D., Pugliese, G., Salzano, C., Savastano, S., & Colao, A. (2019) · Journal of Translational Medicine · doi:10.1186/s12967-019-2104-z · Cited by 180 · see citing works

Obesity and MASLD: Is weight loss the (only) key to treat metabolic liver disease?

Huttasch, M., Roden, M., & Kahl, S. (2024) · Metabolism · doi:10.1016/j.metabol.2024.155937 · Cited by 169 · see citing works

Improvements in clinical characteristics of patients with non-alcoholic fatty liver disease, after an intervention based on the Mediterranean lifestyle: a randomised controlled clinical trial

Katsagoni, C. N., Papatheodoridis, G. V., Ioannidou, P., Deutsch, M., Alexopoulou, A., Papadopoulos, N., Papageorgiou, M.-V., Fragopoulou, E., & Kontogianni, M. D. (2018) · British Journal of Nutrition · doi:10.1017/s000711451800137x · Cited by 167 · see citing works

The effects of foods on LDL cholesterol levels: A systematic review of the accumulated evidence from systematic reviews and meta-analyses of randomized controlled trials

Schoeneck, M., & Iggman, D. (2021) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2020.12.032 · Cited by 161 · see citing works

Fructose and the Liver

Muriel, P., López‐Sánchez, P., & Ramos‐Tovar, E. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22136969 · Cited by 159 · see citing works

Diet-Derived Antioxidants and Their Role in Inflammation, Obesity and Gut Microbiota Modulation

Deledda, A., Annunziata, G., Tenore, G. C., Palmas, V., Manzin, A., & Velluzzi, F. (2021) · Antioxidants · doi:10.3390/antiox10050708 · Cited by 153 · see citing works

Epidemiology and pathophysiology of the association between NAFLD and metabolically healthy or metabolically unhealthy obesity

Lonardo, A., Mantovani, A., Lugari, S., & Targher, G. (2020) · Annals of Hepatology · doi:10.1016/j.aohep.2020.03.001 · Cited by 150 · see citing works

Docosahexaenoic Acid Attenuates Hepatic Inflammation, Oxidative Stress, and Fibrosis without Decreasing Hepatosteatosis in a Ldlr Mouse Model of Western Diet-Induced Nonalcoholic Steatohepatitis

Depner, C. M., Philbrick, K. A., & Jump, D. Β. (2013) · Journal of Nutrition · doi:10.3945/jn.112.171322 · Cited by 145 · see citing works

Diet-Induced Models of Non-Alcoholic Fatty Liver Disease: Food for Thought on Sugar, Fat, and Cholesterol

Eng, J., & Estall, J. L. (2021) · Cells · doi:10.3390/cells10071805 · Cited by 136 · see citing works

The Influence of Dietary Fat on Liver Fat Accumulation

Green, C., & Hodson, L. (2014) · Nutrients · doi:10.3390/nu6115018 · Cited by 129 · see citing works

Lifestyle changes in patients with non-alcoholic fatty liver disease: a systematic review and meta-analysis

Fernández, T., Viñuela, M., Vidal, C., & Barrera, F. (2022) · PLoS ONE · doi:10.1371/journal.pone.0263931 · Cited by 117 · see citing works

Extrahepatic Manifestations of Nonalcoholic Fatty Liver Disease

Li, A. A., Ahmed, A., & Kim, D. (2019) · Gut and Liver · doi:10.5009/gnl19069 · Cited by 108 · see citing works

Plant‐Based Foods and Their Bioactive Compounds on Fatty Liver Disease: Effects, Mechanisms, and Clinical Application

Li, H., Gan, R., Shang, A., Mao, Q., Quan-cai, S., Wu, D., Geng, F., He, X.-Q., & Li, H. (2021) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2021/6621644 · Cited by 108 · see citing works

A systematic review and a dose-response meta-analysis of coffee dose and nonalcoholic fatty liver disease

Chen, Y.-P., Lu, F.-B., Hu, Y.-B., Xu, L.-M., Zheng, M.-H., & Hu, E.-D. (2019) · Clinical Nutrition · doi:10.1016/j.clnu.2018.11.030 · Cited by 106 · see citing works

The effect of coffee consumption on the non-alcoholic fatty liver disease and liver fibrosis: a meta-analysis of 11 epidemiological studies

Hayat, U., Siddiqui, A. A., Okut, H., Afroz, S., Tasleem, S., & Haris, A. (2021) · Annals of Hepatology · doi:10.1016/j.aohep.2020.08.071 · Cited by 105 · see citing works

Role of Oxidative Stress and Lipid Peroxidation in the Pathophysiology of NAFLD

Martín-Fernández, M., Arroyo, V., Carnicero, C., Sigüenza, R., Busta, R., Mora, N., Antolín, B., Tamayo, E., Aspichueta, P., Carnicero-Frutos, I., et al. (2022) · Antioxidants · doi:10.3390/antiox11112217 · Cited by 95 · see citing works

Improvement in histological endpoints of MAFLD following a 12-week aerobic exercise intervention

O’Gorman, P., Naimimohasses, S., Monaghan, A., Kennedy, M., Melo, A. M., Ní Fhloinn, D., Doherty, D. G., Beddy, P., Finn, S. P., Moore, J. B., et al. (2020) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.15989 · Cited by 94 · see citing works

Timing of energy intake and the therapeutic potential of intermittent fasting and time-restricted eating in NAFLD

Marjot, T., Tomlinson, J., Hodson, L., & Ray, D. W. (2023) · Gut · doi:10.1136/gutjnl-2023-329998 · Cited by 87 · see citing works

Calorie-Restricted Mediterranean and Low-Fat Diets Affect Fatty Acid Status in Individuals with Nonalcoholic Fatty Liver Disease

Ristic-Medic, D., Kovacic, M., Takic, M., Arsic, A., Petrovic, S., Paunovic, M., Jovicic, M., & Vucic, V. (2020) · Nutrients · doi:10.3390/nu13010015 · Cited by 81 · see citing works

Effect of Omega‐3 Polyunsaturated Fatty Acids on Lipid Metabolism in Patients With Metabolic Syndrome and NAFLD

Smid, V., Dvořák, K., Šedivý, P., Kosek, V., Martin Lenicek, A., Dezortová, M., Hajšlová, J., Hájek, M., Vı́tek, L., Bechyňská, K., et al. (2022) · Hepatology Communications · doi:10.1002/hep4.1906 · Cited by 77 · see citing works

Effect of exercise on hepatic steatosis: Are benefits seen without dietary intervention? A systematic review and <scp>meta‐analysis</scp>

Baker, C. J., Martinez‐Huenchullan, S. F., D'Souza, M., Xu, Y., Li, M., Bi, Y., Johnson, N. A., & Twigg, S. M. (2021) · Journal of Diabetes · doi:10.1111/1753-0407.13086 · Cited by 69 · see citing works

Could very low-calorie ketogenic diets turn off low grade inflammation in obesity? Emerging evidence

Barrea, L., Caprio, M., Watanabe, M., Cammarata, G., Feraco, A., Muscogiuri, G., Verde, L., Colao, A., & Savastano, S. (2022) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2022.2054935 · Cited by 65 · see citing works

Lipidomics of hepatic lipogenesis inhibition by omega 3 fatty acids

Lamazière, A., Wolf, C., Barbe, U., Bausero, P., & Visioli, F. (2013) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2012.12.001 · Cited by 64 · see citing works

Nonalcoholic fatty liver disease and accelerated loss of skeletal muscle mass: A longitudinal cohort study

Sinn, D. H., Kang, D., Kang, M., Güallar, E., Hong, Y. S., Lee, K. H., Park, J., Cho, J., & Gwak, G. (2022) · Hepatology · doi:10.1002/hep.32578 · Cited by 62 · see citing works

Dietary and pharmacological treatment in patients with metabolic-dysfunction associated steatotic liver disease

Armandi, A., & Bugianesi, E. (2024) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2024.01.005 · Cited by 60 · see citing works

Dietary fiber intake and non-alcoholic fatty liver disease: The mediating role of obesity

Zhu, Y., Hu, Y., Zhang, Y., Rao, S., Mo, Y., Zhang, H., Liang, S., Zhang, Z., & Yang, W. (2023) · Frontiers in Public Health · doi:10.3389/fpubh.2022.1038435 · Cited by 53 · see citing works

A New Nomenclature for the Very Low-Calorie Ketogenic Diet (VLCKD): Very Low-Energy Ketogenic Therapy (VLEKT). Ketodiets and Nutraceuticals Expert Panels: “KetoNut”, Italian Society of Nutraceuticals (SINut) and the Italian Association of Dietetics and Clinical Nutrition (ADI)

Barrea, L., Caprio, M., Grassi, D., Cicero, A. F. G., Bagnato, C., Paolini, B., & Muscogiuri, G. (2024) · Current Nutrition Reports · doi:10.1007/s13668-024-00560-w · Cited by 50 · see citing works

Ketogenic nutritional therapy (KeNuT)—a multi-step dietary model with meal replacements for the management of obesity and its related metabolic disorders: a consensus statement from the working group of the Club of the Italian Society of Endocrinology (SIE)—diet therapies in endocrinology and metabolism

Barrea, L., Caprio, M., Camajani, E., Verde, L., Perrini, S., Cignarelli, A., Prodam, F., Gambineri, A., Isidori, A. M., Colao, A., et al. (2024) · Journal of Endocrinological Investigation · doi:10.1007/s40618-023-02258-2 · Cited by 49 · see citing works

Coffee consumption is associated with lower liver stiffness: a nationally representative study

Niezen, S., Mehta, M., Jiang, Z. G., & Tapper, E. B. (2022) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2021.09.042 · Cited by 47 · see citing works

Effects of an Eight Week Very Low-Calorie Ketogenic Diet (VLCKD) on White Blood Cell and Platelet Counts in Relation to Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) in Subjects with Overweight and Obesity

Nucci, S. D., Bonfiglio, C., Donvito, R., Chito, M. D., Cerabino, N., Rinaldi, R., Sila, A., Shahini, E., Giannuzzi, V., Pesole, P. L., et al. (2023) · Nutrients · doi:10.3390/nu15204468 · Cited by 44 · see citing works

Putting the pyramid into action: the Healthy Eating Index and Food Quality Score.

Kennedy, E. (2008) · PubMed · Cited by 43 · see citing works

Lysosomal Acid Lipase as a Molecular Target of the Very Low Carbohydrate Ketogenic Diet in Morbidly Obese Patients: The Potential Effects on Liver Steatosis and Cardiovascular Risk Factors

Ministrini, S., Calzini, L., Migliola, E. N., Ricci, M. A., Roscini, A. R., Siepi, D., Tozzi, G., Daviddi, G., Martorelli, E. E., Paganelli, M. T., et al. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8050621 · Cited by 41 · see citing works

Fructose: a modulator of intestinal barrier function and hepatic health?

Staltner, R., Burger, K., Baumann, A., & Bergheim, I. (2023) · European Journal of Nutrition · doi:10.1007/s00394-023-03232-7 · Cited by 40 · see citing works

Molecular Mechanisms of Curcumin in the Pathogenesis of Metabolic Dysfunction Associated Steatotic Liver Disease

Guariglia, M., Saba, F., Rosso, C., & Bugianesi, E. (2023) · Nutrients · doi:10.3390/nu15245053 · Cited by 39 · see citing works

Does Resveratrol Improve Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)?

Kasprzak‐Drozd, K., Niziński, P., Kasprzak, P., Kondracka, A., Oniszczuk, T., Rusinek, A., & Oniszczuk, A. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25073746 · Cited by 37 · see citing works

Dietary macro and micronutrients associated with MASLD: Analysis of a national US cohort database

Nemer, M., Osman, F., & Said, A. (2024) · Annals of Hepatology · doi:10.1016/j.aohep.2024.101491 · Cited by 35 · see citing works

Effects of vitamin D supplementation on liver fibrogenic factors, vitamin D receptor and liver fibrogenic microRNAs in metabolic dysfunction-associated steatotic liver disease (MASLD) patients: an exploratory randomized clinical trial

Ebrahimpour‐Koujan, S., Sohrabpour, A. A., Giovannucci, E. L., Vatannejad, A., & Esmaillzadeh, A. (2024) · Nutrition Journal · doi:10.1186/s12937-024-00911-x · Cited by 35 · see citing works

Non-Pharmacological Approach to Diet and Exercise in Metabolic-Associated Fatty Liver Disease: Bridging the Gap between Research and Clinical Practice

Ali, H., Shahzil, M., Moond, V., Shahzad, M., Thandavaram, A., Sehar, A., Waseem, H., Siddiqui, T. A., Dahiya, D. S., Patel, P., et al. (2024) · Journal of Personalized Medicine · doi:10.3390/jpm14010061 · Cited by 34 · see citing works

Gender Differences in Liver Steatosis and Fibrosis in Overweight and Obese Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease before and after 8 Weeks of Very Low-Calorie Ketogenic Diet

Rinaldi, R., Nucci, S. D., Donghia, R., Donvito, R., Cerabino, N., Chito, M. D., Penza, A., Mongelli, F. P., Shahini, E., Zappimbulso, M., et al. (2024) · Nutrients · doi:10.3390/nu16101408 · Cited by 34 · see citing works

Silymarin decreases liver stiffness associated with gut microbiota in patients with metabolic dysfunction-associated steatotic liver disease: a randomized, double-blind, placebo-controlled trial

Jin, Y., Wang, X., Chen, K., Chen, Y., Zhou, L., Zeng, Y., Zhou, Y., Pan, Z., Wang, D., Li, Z., et al. (2024) · Lipids in Health and Disease · doi:10.1186/s12944-024-02220-y · Cited by 34 · see citing works

Evening chronotype is associated with severe NAFLD in obesity

Vetrani, C., Barrea, L., Verde, L., Sarno, G., Docimo, A., de Alteriis, G., Savastano, S., Colao, A., & Muscogiuri, G. (2022) · International Journal of Obesity · doi:10.1038/s41366-022-01159-3 · Cited by 33 · see citing works

The Antioxidant Potential of the Mediterranean Diet as a Predictor of Weight Loss after a Very Low-Calorie Ketogenic Diet (VLCKD) in Women with Overweight and Obesity

Verde, L., Dalamaga, Μ., Capó, X., Annunziata, G., Hassapidou, M. N., Docimo, A., Savastano, S., Colao, A., Muscogiuri, G., & Barrea, L. (2022) · Antioxidants · doi:10.3390/antiox12010018 · Cited by 32 · see citing works

Effect of a Low-Calorie Dietary Intervention on Liver Health and Body Weight in Adults with Metabolic-Dysfunction Associated Steatotic Liver Disease (MASLD) and Overweight/Obesity: A Systematic Review and Meta-Analysis

Dobbie, L. J., Burgess, J., Hamid, A., Nevitt, S. J., Hydes, T., Alam, U., & Cuthbertson, D. J. (2024) · Nutrients · doi:10.3390/nu16071030 · Cited by 32 · see citing works

Inflammatory markers as diagnostic and precision nutrition tools for metabolic dysfunction-associated steatotic liver disease: Results from the Fatty Liver in Obesity trial

Mogna-Peláez, P., Riezu‐Boj, J. I., Milagro, F. I., Herrero, J. I., Elorz, M., Benito, A., Tobaruela-Resola, A. L., Tur, J. A., Martínez, J. A., Abete, I., et al. (2024) · Clinical Nutrition · doi:10.1016/j.clnu.2024.05.042 · Cited by 32 · see citing works

Dietary wheat amylase trypsin inhibitors promote features of murine non-alcoholic fatty liver disease

Ashfaq–Khan, M., Aslam, M., Qureshi, M. A., Senkowski, M., Yen-Weng, S., Strand, S., Kim, Y. O., Pickert, G., Schattenberg, J. M., & Schuppan, D. (2019) · Scientific Reports · doi:10.1038/s41598-019-53323-x · Cited by 31 · see citing works

The effects of synbiotics on the liver steatosis, inflammation, and gut microbiome of metabolic dysfunction-associated liver disease patients-randomized trial

Mitrović, M., Dobrosavljević, A., Odanović, O., Ivanovski, T. K., Kralj, D., Erceg, S., Perućica, A., Svorcan, P., & Stanković-Popović, V. (2024) · Romanian Journal of Internal Medicine · doi:10.2478/rjim-2024-0004 · Cited by 26 · see citing works

The impact of short-term eucaloric low- and high-carbohydrate diets on liver triacylglycerol content in males with overweight and obesity: a randomized crossover study

London, A., Richter, M. M., Sjøberg, K. A., Albrechtsen, N. J. W., Považan, M., Drici, L., Schaufuss, A., Madsen, L., Øyen, J., Madsbad, S., et al. (2024) · American Journal of Clinical Nutrition · doi:10.1016/j.ajcnut.2024.06.006 · Cited by 26 · see citing works

Adherence to Mediterranean Diet: Any Association with NAFLD?

Barrea, L., Verde, L., Savastano, S., Colao, A., & Muscogiuri, G. (2023) · Antioxidants · doi:10.3390/antiox12071318 · Cited by 24 · see citing works

The Potential Role of Polyphenols in Modulating Mitochondrial Bioenergetics within the Skeletal Muscle: A Systematic Review of Preclinical Models

Mthembu, S. X. H., Dludla, P. V., Ziqubu, K., Nyambuya, T. M., Kappo, A. P., Madoroba, E., Nyawo, T. A., Nkambule, B. B., Silvestri, S., Muller, C. J. F., et al. (2021) · Molecules · doi:10.3390/molecules26092791 · Cited by 23 · see citing works

The Many Faces of Metabolic Dysfunction-Associated Fatty Liver Disease Treatment: From the Mediterranean Diet to Fecal Microbiota Transplantation

Abenavoli, L., Gambardella, M. L., Scarlata, G. G. M., Lenci, I., Baiocchi, L., & Luzza, F. (2024) · Medicina · doi:10.3390/medicina60040563 · Cited by 23 · see citing works

Guideline-based management of metabolic dysfunction-associated steatotic liver disease in the primary care setting

Allen, A. M., Charlton, M., Cusi, K. J., Harrison, S. A., Kowdley, K. V., Noureddin, M., & Shubrook, J. H. (2024) · Postgraduate Medicine · doi:10.1080/00325481.2024.2325332 · Cited by 22 · see citing works

Intermittent fasting regimens for metabolic dysfunction-associated steatotic liver disease: a systematic review and network meta-analysis of randomized controlled trials

Abuelazm, M. T., Mohamed, I., Naeem, A., Khlidj, Y., Tanashat, M., Katamesh, B. E., Abusuilik, H., Altobaishat, O., Abdelnabi, M., & Abdelazeem, B. (2024) · European Journal of Gastroenterology &amp; Hepatology · doi:10.1097/meg.0000000000002715 · Cited by 21 · see citing works

Potential of Chlorogenic Acid in the Management of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): Animal Studies and Clinical Trials—A Narrative Review

Ziółkiewicz, A., Niziński, P., Soja, J., Oniszczuk, T., Combrzyński, M., Kondracka, A., & Oniszczuk, A. (2024) · Metabolites · doi:10.3390/metabo14060346 · Cited by 21 · see citing works

Effects of short‐term supervised exercise training on liver fat in adolescents with obesity: a randomized controlled trial

Tas, E., Landes, R. D., Diaz, E. C., Bai, S., Ou, X., Buchmann, R. F., Na, X., Muzumdar, R. H., Børsheim, E., & Dranoff, J. A. (2023) · Obesity · doi:10.1002/oby.23887 · Cited by 19 · see citing works

Can Nutraceuticals Support the Treatment of MASLD/MASH, and thus Affect the Process of Liver Fibrosis?

Sokal-Dembowska, A., Jarmakiewicz-Czaja, S., Ferenc, K., & Filip, R. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25105238 · Cited by 19 · see citing works

Associations between dietary fatty acid patterns and non-alcoholic fatty liver disease in typical dietary population: A UK biobank study

Tian, A., Sun, Z., Zhang, M., Li, J., Pan, X., & Chen, P. (2023) · Frontiers in Nutrition · doi:10.3389/fnut.2023.1117626 · Cited by 18 · see citing works

Short‐term reduction of dietary gluten improves metabolic‐dysfunction associated steatotic liver disease: A randomised, controlled proof‐of‐concept study

Armandi, A., Bespaljko, H., Mang, A., Huber, Y., Michel, M. S., Labenz, C., Galle, P. R., Neerukonda, M., Bugianesi, E., Schuppan, D., et al. (2024) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.17941 · Cited by 18 · see citing works

Celiac Disease, Gluten-Free Diet and Metabolic Dysfunction-Associated Steatotic Liver Disease

Cazac, G.-D., Mihai, B. M., Ștefănescu, G., Gîlcă-Blanariu, G.-E., Mihai, C., Grigorescu, E.-D., Onofriescu, A., & Lăcătușu, C.-M. (2024) · Nutrients · doi:10.3390/nu16132008 · Cited by 18 · see citing works

Higher-Level Steatosis Is Associated with a Greater Decrease in Metabolic Dysfunction-Associated Steatoic Liver Disease after Eight Weeks of a Very Low-Calorie Ketogenic Diet (VLCKD) in Subjects Affected by Overweight and Obesity

Sila, A., Nucci, S. D., Bonfiglio, C., Stasi, V. D., Cerabino, N., Chito, M. D., Rinaldi, R., Cantalice, P., Shahini, E., Giannuzzi, V., et al. (2024) · Nutrients · doi:10.3390/nu16060874 · Cited by 17 · see citing works

Supplementation with medium-chain fatty acids increases body weight loss during very low-calorie ketogenic diet: a retrospective analysis in a real-life setting

Vetrani, C., Verde, L., Savastano, S., Colao, A., Muscogiuri, G., & Barrea, L. (2023) · Journal of Translational Medicine · doi:10.1186/s12967-023-03880-7 · Cited by 16 · see citing works

Intermittent fasting: a new trend or a valid approach for the treatment of obesity?

Annunziata, G., Capó, X., Muscogiuri, G., Colao, A., & Barrea, L. (2023) · Minerva Endocrinology · doi:10.23736/s2724-6507.23.04100-3 · Cited by 15 · see citing works

Effects of silymarin use on liver enzymes and metabolic factors in metabolic dysfunction-associated steatotic liver disease: a systematic review and meta-analysis

Malik, A., Malik, M., & Qureshi, S. (2024) · Canadian Liver Journal · doi:10.3138/canlivj-2023-0021 · Cited by 15 · see citing works

A Healthful Plant-Based Diet as an Alternative Dietary Approach in the Management of Metabolic Dysfunction-Associated Steatotic Liver Disease

Castelnuovo, G., Pérez-Díaz-Del-Campo, N., Rosso, C., Armandi, A., Caviglia, G., & Bugianesi, E. (2024) · Nutrients · doi:10.3390/nu16132027 · Cited by 14 · see citing works

Mediators of dietary diversity score (DDS) on NAFLD in Iranian adults: a structural equation modeling study

Doustmohammadian, A., Amirkalali, B., Gholizadeh, E., Khoonsari, M., Faraji, A. H., Nikkhah, M., Maadi, M., Motamed, N., Mansourian, M. R., Hajjar, M., et al. (2022) · European Journal of Clinical Nutrition · doi:10.1038/s41430-022-01240-0 · Cited by 13 · see citing works

Diet quality indices and odds of metabolic dysfunction-associated fatty liver disease: a case-control study

Ramaiah, P., Baljon, K. J., Alsulami, S. A., Lindsay, G., & Chinnasamy, L. (2024) · Frontiers in Nutrition · doi:10.3389/fnut.2023.1251861 · Cited by 13 · see citing works

Ramadan Fasting in Individuals with Metabolic Dysfunction-Associated Steatotic Liver Disease, Liver Transplant, and Bariatric Surgery: A Narrative Review

Ahmed, M., & Ahmed, M. H. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13133893 · Cited by 11 · see citing works

Interplay of Mediterranean-diet adherence, genetic factors, and metabolic dysfunction-associated steatotic liver disease risk in Korea

Kwon, Y., Choi, J., Hong, K., & Lee, J. (2024) · Journal of Translational Medicine · doi:10.1186/s12967-024-05408-z · Cited by 11 · see citing works

Greater hepatic lipid saturation is associated with impaired glycaemic regulation in men with metabolic dysfunction‐associated steatotic liver disease but is not altered by 6 weeks of exercise training

Willis, S. A., Malaikah, S., Bawden, S. J., Sherry, A. P., Sargeant, J. A., Coull, N. A., Bradley, C. R., Rowlands, A., Naim, I., Ennequin, G., et al. (2024) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.15755 · Cited by 9 · see citing works

Influence of Lipid Class Used for Omega-3 Fatty Acid Supplementation on Liver Fat Accumulation in MASLD

Sabinari, I. W., Horakova, O., Čajka, T., Kleinova, V., Wieckowski, M. R., & Rossmeisl, M. (2024) · Physiological Research · doi:10.33549/physiolres.935396 · Cited by 6 · see citing works

Efficacy of the Regional Mexican Diet versus the Mediterranean Diet in Patients with MASLD: A 24-Week Non-Inferiority Trial

Cano-Contreras, A. D., Carvajal, M. G., Martínez-Pérez, G. P., Lorenzo, A. A. O., Francisco, M. D. R. R., Alvarez, H. R. O., Dietlen, F. B. R., & Remes-Troche, J. M. (2024) · Revista Española de Enfermedades Digestivas · doi:10.17235/reed.2024.10392/2024 · Cited by 3 · see citing works

Metabolic Dysfunction‐Associated Steatotic Liver Disease ( MASLD ): Mechanisms, Clinical Implications and Therapeutic Advances

Miller, D. M., McCauley, K. F., & Dunham‐Snary, K. J. (2025) · Endocrinology Diabetes & Metabolism · doi:10.1002/edm2.70132 · Cited by 125 · see citing works

Unlocking Polyphenol Efficacy: The Role of Gut Microbiota in Modulating Bioavailability and Health Effects

Mahdi, L., Graziani, A., Baffy, G., Mitten, E. K., Portincasa, P., & Khalil, M. (2025) · Nutrients · doi:10.3390/nu17172793 · Cited by 97 · see citing works

Chrononutrition and Energy Balance: How Meal Timing and Circadian Rhythms Shape Weight Regulation and Metabolic Health

Reytor-González, C., Simancas-Racines, D., Román-Galeano, N. M., Annunziata, G., Galasso, M., Zambrano-Villacres, R., Verde, L., Muscogiuri, G., Frias-Toral, E., & Barrea, L. (2025) · Nutrients · doi:10.3390/nu17132135 · Cited by 88 · see citing works

The Impact of Dietary Interventions on Metabolic Outcomes in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) and Comorbid Conditions, Including Obesity and Type 2 Diabetes

Jurek, J. M., Zabłocka-Słowińska, K. A., Clavero-Mestres, H., Gutiérrez, L. R., Camaron, J., & Auguet, T. (2025) · Nutrients · doi:10.3390/nu17071257 · Cited by 39 · see citing works

Obesity and endometrial cancer: biological mechanisms, nutritional strategies, and clinical perspectives

Simancas‐Racines, D., Campuzano-Donoso, M., Román-Galeano, N. M., Zambrano-Villacres, R., Memoli, P., Verde, L., Reytor-González, C., & Carbone, L. (2025) · Food and Agricultural Immunology · doi:10.1080/09540105.2025.2510961 · Cited by 29 · see citing works

Advancing precision medicine in metabolic dysfunction-associated steatotic liver disease.

Priego-Parra, B., Gallego-Durán, R., Román-Calleja, B., Velasco, J. V.-R., Romero-Gómez, M., & Gracia-Sancho, J. (2025) · Trends in endocrinology and metabolism · doi:10.1016/j.tem.2025.03.006 · Cited by 25 · see citing works

Obesity and breast cancer: exploring the nexus of chronic inflammation, metabolic dysregulation, and nutritional strategies

Reytor-González, C., Simancas-Racines, D., Román-Galeano, N., Campuzano-Donoso, M., Carella, A. M., Zambrano-Villacres, R., Marinelli, T., Coppola, L., Marchetti, M., Galasso, M., et al. (2025) · Food and Agricultural Immunology · doi:10.1080/09540105.2025.2521270 · Cited by 19 · see citing works

Providing holistic care for patients with m etabolic dysfunction‐associated steatotic liver disease/metabolic dysfunction‐associated steatohepatitis: Key aspects of clinical assessment and how to develop individualised care plans for surveillance and interventions

Chen, L., Horn, P., & Tacke, F. (2026) · Diabetes Obesity and Metabolism · doi:10.1111/dom.70545 · Cited by 20 · see citing works

Two-Year Mediterranean Diet Intervention Improves Hepatic Health in MASLD Patients

Monserrat-Mesquida, M., Bouzas, C., García, S., Mateos, D., Casares, M., Ugarriza, L., Gómez, C., Sureda, A., & Tur, J. A. (2025) · Foods · doi:10.3390/foods14101736 · Cited by 19 · see citing works

Redefining Chemoresistance: Natural Bioactives as Molecular Modulators at the Cancer–Tumor Microenvironment Interface

Reytor-González, C., Jiménez-Flores, E., González, N., & Simancas-Racines, D. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26168037 · Cited by 13 · see citing works

Effectiveness of Medical Nutrition Therapy in the Management of Patients with Obesity and Endometriosis: from the Mediterranean Diet To the Ketogenic Diet, Through Supplementation. The Role of the Nutritionist in Clinical Management

Barrea, L., Verde, L., Annunziata, G., Chedraui, P. A., Petraglia, F., Cucalón, G., Camajani, E., Caprio, M., Gorini, S., Iorio, G. G., et al. (2025) · Current Obesity Reports · doi:10.1007/s13679-025-00662-8 · Cited by 23 · see citing works

Advancing Obesity Management: the Very Low-Energy Ketogenic therapy (VLEKT) as an Evolution of the “Traditional” Ketogenic Diet

Balestra, F., Luca, M. D., Panzetta, G., Palieri, R., Shahini, E., Giannelli, G., Pergola, G. D., & Scavo, M. P. (2025) · Current Obesity Reports · doi:10.1007/s13679-025-00622-2 · Cited by 15 · see citing works

Harnessing nutrition to combat MASLD: a comprehensive guide to food-based therapeutic strategies

Reytor-González, C., Simancas‐Racines, D., Campuzano-Donoso, M., Jimenez, J. C., Román-Galeano, N. M., Sarno, G., & Frías-Toral, E. (2025) · Food and Agricultural Immunology · doi:10.1080/09540105.2025.2496499 · Cited by 15 · see citing works

Navigating the weight: The impact of obesity on gastrointestinal cancer surgery and strategies for improved outcomes

Sarno, G., Reytor-González, C., Frías-Toral, E., Campuzano-Donoso, M., Katsanos, C. S., & Simancas‐Racines, D. (2025) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2025.06.010 · Cited by 12 · see citing works

Imeglimin ameliorates MASLD by targeting PEN2 to activate AMPK pathway

Li, J., Zhang, R., Zeng, X. Y., Xu, W., Gao, L., He, S., Bingbing, W., Ma, Y., Nie, Y., Shirakawa, J., et al. (2025) · Metabolism · doi:10.1016/j.metabol.2025.156458 · Cited by 12 · see citing works

Ultra-Processed Foods and Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): What Is the Evidence So Far?

Geladari, E. V., Kounatidis, D. C., Christodoulatos, G. S., Psallida, S., Pavlou, A., Geladari, C. V., Sevastianos, V., Dalamaga, Μ., & Vallianou, N. G. (2025) · Nutrients · doi:10.3390/nu17132098 · Cited by 13 · see citing works

Oesophageal adenocarcinoma, obesity, and cancer: the role of nutrition in prevention and management

Reytor-González, C., Simancas‐Racines, D., Jiménez-Flores, E., Campuzano-Donoso, M., Am, C., Coppola, L., Marchetti, M., Zambrano-Villacres, R., & Sarno, G. (2025) · Food and Agricultural Immunology · doi:10.1080/09540105.2025.2510951 · Cited by 12 · see citing works

Noninvasive tests and diagnostic pathways to MASH diagnosis in the United States: a retrospective observational study

Gbadamosi, S. O., Evans, K. A., Brady, B. L., & Hoovler, A. (2025) · Journal of Medical Economics · doi:10.1080/13696998.2025.2468582 · Cited by 10 · see citing works

Insulin resistance: mechanisms and therapeutic interventions

Yu, L., Qian, J., Li, X., Tian, M., Bai, X., Yang, J., Deng, R., Lu, C., He, X., Lü, A., et al. (2026) · Molecular Biomedicine · doi:10.1186/s43556-026-00408-5 · Cited by 9 · see citing works

Beyond Weight Loss: Comparative Effects of Tirzepatide Plus Low-Energy Ketogenic Versus Low-Calorie Diet on Hepatic Steatosis and Stiffness in MASLD

Schiavo, L., Santella, B., Mingo, M., Rossetti, G., Orio, M., & Pilone, V. (2025) · Nutrients · doi:10.3390/nu17152409 · Cited by 7 · see citing works

Metabolic and hepatic biomarkers associated with MASLD in the Chinese population

Chen, H., Chen, Z., Bai, X., Li, Z., Huang, S., Li, J., Li, J., Wang, Y., Han, L., Xia, K., et al. (2025) · Scientific Reports · doi:10.1038/s41598-025-17219-3 · Cited by 7 · see citing works

From meal to malfunction: exploring molecular pathways, biomarkers and interventions in postprandial cardiometabolic health

Reytor-González, C., Cevallos-Fernández, E., Jácome, B., & Simancas-Racines, D. (2025) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2025.1655889 · Cited by 7 · see citing works

Milpa Diet for MASLD in Mesoamerican Populations: Feasibility, Advantages, and Future Perspectives

Huerta-Álvarez, A., Arellano, M., Chávez-Méndez, C. A., Carpinteyro‐Espín, P., Palacios‐Reyes, C., & Pérez-Escobar, J. (2025) · Life · doi:10.3390/life15050812 · Cited by 6 · see citing works

Association between the dietary index for gut microbiota and all-cause/cardiovascular mortality in patients with metabolic dysfunction-associated steatotic liver disease

Wu, W., Cheng, J., Hou, Z., Yan, Q., Wang, X., He, J., Zhu, Y., & Li, J. (2025) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-025-01846-x · Cited by 6 · see citing works

Nutrition and longevity – diet in centenarians

Frias-Toral, E., Reytor-González, C., Annunziata, G., Verde, L., Jiménez-Flores, E., Sen, K., Galasso, M., Muscogiuri, G., Simancas‐Racines, D., Dalamaga, Μ., et al. (2026) · Journal of Translational Medicine · doi:10.1186/s12967-026-07691-4 · Cited by 6 · see citing works

Epicardial fat thickness is increased in menopausal patients in comparison with premenopausal patients with similar excess weight: a cross-sectional study

Gangitano, E., Barbaro, G., Gnessi, L., Iacobellis, G., & Lubrano, C. (2025) · Journal of Translational Medicine · doi:10.1186/s12967-025-06335-3 · Cited by 6 · see citing works

Association of the dietary index for gut microbiota and dietary inflammation index with metabolic dysfunction-associated steatotic liver disease and metabolic alcohol-associated liver disease

Wu, W., & Hou, Z. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1593245 · Cited by 6 · see citing works

The Seven Methods for the Evaluation of Nutritional Status—ABCDEFG: Narrative Review

Zambrano-Villacres, R., Arteaga-Pazmiño, C., Guevara Castillo, W. D., Herrera-Fontana, M. E., Domínguez Brito, L. D., Becerra Granados, L. M., Recoba-Obregón, P. E., Rodríguez-Veintimilla, D., Bressi, V., Andrade-Molina, D., et al. (2026) · Applied Sciences · doi:10.3390/app16020845 · Cited by 5 · see citing works

Barriers and facilitators to non-pharmacological management of metabolic dysfunction-associated steatotic liver disease: a qualitative evidence synthesis

Yilmaz, Y. N. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1615809 · Cited by 5 · see citing works

Alcohol and Substance Use After Bariatric Surgery: Nutritional Risks and Clinical Implications in Long-Term Postoperative Care

Campuzano-Donoso, M., Reytor-González, C., Sarno, G., Montalván, M., Barrea, L., Muscogiuri, G., Verde, L., Annunziata, G., & Simancas-Racines, D. (2026) · Nutrients · doi:10.3390/nu18060932 · Cited by 5 · see citing works

Socioeconomic disparities and nutritional aging: how food insecurity and financial hardship accelerate health decline in older adults

Reytor-González, C., Campuzano-Donoso, M., Román-Galeano, N. M., Jiménez, Paz-Yépez, C., Montalván, M., & Simancas‐Racines, D. (2026) · Frontiers in Nutrition · doi:10.3389/fnut.2026.1833736 · Cited by 5 · see citing works

Associations of healthy eating index 2020 and its components with non-alcoholic fatty liver disease in type 2 diabetes patients and the mediating roles of metabolic indicators: NHANES 2007–2018

Chen, J., Diao, H., Zhang, Y., Hu, B., Qian, K., Zhang, K., Zhang, T., & Song, J. (2025) · Frontiers in Nutrition · doi:10.3389/fnut.2025.1564197 · Cited by 5 · see citing works

Gut microbiota and metabolic syndrome in postmenopausal women: a narrative review of mechanisms and dietary recommendations

Chapela, S. P., Locatelli, J., Toral-Noristz, M., Saettone, F., Llobera, N. D., BASTIDAS, S., SÁNCHEZ, M., Arteaga-Pazmiño, C. L., Chedraui, P., Ceriani, F., et al. (2026) · Minerva Endocrinology · doi:10.23736/s2724-6507.25.04483-5 · Cited by 5 · see citing works

Hydroxytyrosol Improves Metabolic Dysfunction-Associated Fatty Liver Disease Dependent on the Modulation of Gut Microbiota

Xiao, Y., Zhang, X., Shao, B., Wu, Z., Li, X., Yi, D., Li, T., Yang, T., Zhu, J.-X., Huang, T., et al. (2025) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.5c07003 · Cited by 4 · see citing works

Broccoli-Derived Exosome-like Nanoparticles Alleviates Metabolic Dysfunction-Associated Steatotic Liver Disease Through Modulating the Gut–Liver Axis

Zhang, F., Liu, R., Xu, T., Xu, W., Huang, K., & He, X. (2026) · Nutrients · doi:10.3390/nu18060953 · Cited by 3 · see citing works

Beyond medication: Unveiling the role of diet and lifestyle in fatty liver disease management

Ul‐Haq, I., Nadeem, M., Sharma, A., Mugabi, R., Waseem, M., & Nayik, G. A. (2025) · Human Nutrition & Metabolism · doi:10.1016/j.hnm.2025.200317 · Cited by 3 · see citing works

The Molecular Mechanisms Underlying Dercum’s Disease: Exploring the Intersection of Obesity, Pain, and Inflammation

Reytor-González, C., Jiménez-Flores, E., Toral-Noristz, M., Campuzano-Donoso, M., Román-Galeano, N. M., & Simancas‐Racines, D. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms262211130 · Cited by 2 · see citing works

Prebiotic and Probiotic Foods in MASLD: Microbiome-Mediated Therapeutic Strategies

Cui, B., Liu, Y., Joyce, H., Jieying, C., Jia-hang, X., Jian-Peng, T., & Chun, L. H. (2025) · Synthetic biology and engineering · doi:10.70322/sbe.2025.10018 · Cited by 2 · see citing works

Longevity, Centenarians, and Lifestyle: Any ‘’Tips’’ to Live Longer?

Vetrani, C., Frias-Toral, E., Annunziata, G., Amatrudo, F., Mayol, D., Suárez, R., Verde, L., Negri, M., Piscitelli, P., Colao, A., et al. (2026) · Current Nutrition Reports · doi:10.1007/s13668-025-00724-2 · Cited by 2 · see citing works

Protective effects of Bambusa vulgaris leaves extract on high-fat diet-induced MASLD: insights from in silico and in vivo study

Sarkar, S., Das, S., Ghosh, A., Goswami, R. C. D., & Choudhuri, D. (2026) · 3 Biotech · doi:10.1007/s13205-026-04735-w · Cited by 2 · see citing works

Advances in the Pharmacologic Management of MASLD

Madhankumar, S., & Asma, A. (2026) · Gastroenterology Insights · doi:10.3390/gastroent17010017 · Cited by 2 · see citing works

Fiber-Dependent Microbiome Glycine Lipids Ameliorate Steatotic Liver Disease in Mice via Mitochondrial Enhancement

Anto, L., Gao, L., Lee, J., Garcia, C., Otoko, O., Hickey, E., Mishra, N., Kim, S., Noh, S. G., Kim, M., et al. (2026) · Gastro Hep Advances · doi:10.1016/j.gastha.2026.101064 · Cited by 2 · see citing works

Multilevel barriers to clinical and nutritional research in Latin America: a socioeconomic comparative analysis

Frias-Toral, E., Angamarca-Iguago, J., Higuera, I. C., CARRIEL-MANCILLA, J., Contreras, G., Franco-Nuñez, R., Larreategui-Arosemena, R., Moscoso, C. P. M., Restrepo, J., Cagua-Ordoñez, J. C., et al. (2025) · Frontiers in Nutrition · doi:10.3389/fnut.2025.1599344 · Cited by 1 · see citing works

Acceptability of Brazzein-Sweetened Ice Cream as a Sugar-Reduction Strategy in Metabolic Dysfunction-Associated Steatotic Liver Disease: A Double-Blind Randomized Crossover Sensory Study

Va, I., Goncharov, A. А., Pilipenko, V. I., Нисановна, С. А., Kochetkova, A. A., & Bessonov, V. V. (2026) · Dairy · doi:10.3390/dairy7030044 · Cited by 1 · see citing works

Herbal, dietary supplements, oligo and trace elements consumption among chronic liver disease patients and caregivers: a cross-sectional study

Licata, A., Ciriminna, S., Tulone, O., Cammilleri, M., Cilona, L., Chianetta, R., Giannitrapani, L., Citarrella, R., Barbagallo, M., & Soresi, M. (2026) · Internal and Emergency Medicine · doi:10.1007/s11739-026-04425-8 · Cited by 1 · see citing works

α-Lack-SPI Alleviates MASLD in Rats via Regulating Hepatic Lipid Accumulation and Inflammation

Chen, M., Guo, S., Lai, X., Xiao, Q., Wu, X., Pang, J., Pei, L., Gu, Y., Zhang, X., & Yang, L. (2025) · Nutrients · doi:10.3390/nu17182918 · Cited by 1 · see citing works

Research progress on extraction and purification, pharmacological activity, pharmacokinetics and content determination of platycodin D

Yang, L., Xiao, X. H., Chai, X., Yin, Z., Zhang, D., Fan, H., Wang, W., Li, Y., & Song, X. (2025) · Medicinal Chemistry Research · doi:10.1007/s00044-025-03479-1

EFEITOS DAS TERAPIAS NUTRICIONAIS NO DESENVOLVIMENTO E TRATAMENTO DA DOENÇA HEPÁTICA GORDUROSA NÃO ALCOÓLICA

Azevedo, S. A. D., Costa, A. C. X., Rego, K. A. D. S., Oliveira, F. D. S., Mantesso, J. B. D. O., Paiva, G. S. C., Falcão, A. D. S., & Mignoni, M. S. P. M. (2025) · Aracê. · doi:10.56238/arev7n11-266

Implication of the Androgen Receptor in Muscle–Liver Crosstalk: An Overlooked Mechanistic Link in Lean-MASLD

Trifylli, E.-M., Charalambous, C. H., Spiliotopoulos, N., Papadopoulos, N., Oikonomou, A., Manolakopoulos, S., & Deutsch, M. J. (2025) · Livers · doi:10.3390/livers5040065

Combined functional lipids modulate lipid metabolism and attenuate metabolic dysregulation in a rat model of cafeteria diet

Suppo, C. L., KUHN, G., Lavandera, J. V., Bernal, C., & Fariña, A. C. (2026) · Journal of Physiology and Biochemistry · doi:10.1007/s13105-026-01157-3

Rapid regression of advanced hepatic fibrosis in a patient with metabolic dysfunction-associated steatotic liver disease and severe obesity: a case report highlighting lifestyle-induced NETosis activation through serum proteomic analysis

Nakamura, T., Bekki, S., Nakano, D., Masuda, A., Amano, K., Nakano, M., & Kawaguchi, T. (2026) · Clinical Journal of Gastroenterology · doi:10.1007/s12328-026-02356-7

Global, regional, and national burden of NAFLD-including cirrhosis, 1990–2021, and forecast to 2050: a cross-sectional analysis of the Global Burden of Disease Study 2021

Chen, J., Gao, D., Lv, X., Zhang, H., Sun, M., Jiang, Y., Lv, Z., Xu, X., & Tang, M. (2026) · International Journal of Surgery · doi:10.1097/js9.0000000000005161

Preventive strategies in hepatology: Role of multiparametric assessment of portal hypertension in chronic liver disease

PELTEC, A. I., & Sporea, I. (2026) · World Journal of Gastroenterology · doi:10.3748/wjg.119106

The effect of high-protein vs. low-protein diets on CRP, IL-6, TNF-α, and liver enzymes in adult participants: a systematic review and meta-analysis

Ma, X., Rohani, P., & Sohouli, M. H. (2026) · Food & Function · doi:10.1039/d5fo04706d

Beyond Inflammation - A Multidisciplinary Approach to Managing Obesity and Cardiometabolic Risk in Inflammatory Bowel Disease

Plush, S., Litwin, P., Han, S., Bryant, R. V., Kumar, S., Kaazan, P., & Day, A. S. (2026) · Current Diabetes Reports · doi:10.1007/s11892-026-01627-4

FcRn-hitchhiking BSA-galactose nanoparticles for liver-targeted delivery of astaxanthin in non-alcoholic fatty liver

Liu, R., Xu, H., Wang, H., Xia, K., Cheng, S., Song, Y., & Tan, M. (2026) · Chemical Engineering Journal · doi:10.1016/j.cej.2026.178514

Diagnostic exogenous probe strategy using ezetimibe-glucuronide effectively identifies metabolic dysfunction–associated steatohepatitis

Farrera, D. O., Frost, K. L., Jilek, J. L., Sample, P. A., Izu, J. M., Alaaldin, M. M., Lindberg, P., Maloney, M. M., Rodrigues, D., Yamaguchi, E., et al. (2026) · Drug Metabolism and Disposition · doi:10.1016/j.dmd.2026.100351

Quinoa regulates hepatic lipid metabolism in MASLD mice via PPARγ-PLIN2

Liu, P., Wan, J., Qiao, L., Zhang, W., Sun, B., Hu, M., Zhang, Y., Jing, X., Wang, Y., Hu, Y., et al. (2026) · Food & Function · doi:10.1039/d6fo00954a

Proteomics advances in screening early diagnostic biomarkers for non-alcoholic fatty liver disease

Chu, X., Yang, L., & Fu, G. (2026) · Current Proteomics · doi:10.1016/j.curpro.2026.100144

Effect of sucrose-free brazzein-sweetened ice cream on continuously monitored glycemic response in patients with metabolic dysfunction-associated steatotic liver disease: A randomized controlled double-blind crossover trial

Va, I., Pilipenko, V. I., Goncharov, A. A., & Нисановна, С. А. (2026) · Clinical Nutrition ESPEN · doi:10.1016/j.clnesp.2026.105066

Adipose Tissue Expandability as a Link Between Nutrition and Obesity-Related Metabolic Risk: Insights from Bariatric Surgery

Jiménez-Flores, E., Reytor-González, C., Gavilanes, D. J., Rossetti, G., Pilone, V., Parrillo, L., Cavallo, M., Cobellis, L., Simancas-Racines, D., & Schiavo, L. (2026) · Nutrients · doi:10.3390/nu18183075

NUTRITIONAL MANAGEMENT OF METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE (MASLD)

Chaturvedi, A. (2026) · Iterative International Publishers eBooks · doi:10.58532/nbennur3358c2

Harnessing nutrition to combat MASLD: a comprehensive guide to food-based therapeutic strategies

Reytor-González, C., Simancas‐Racines, D., Campuzano-Donoso, M., Jimenez, J. C., Román-Galeano, N. M., Sarno, G., & Frías-Toral, E. (2025) · Food and Agricultural Immunology · doi:10.1080/09540105.2025.2496499 · Cited by 15 · see citing works

Nutritional and Fasting Strategies for the Management of MASLD / MASH : An Integrative Review

Tawk, D., Ghader, G., Khatib, Y., Attieh, P., Youssef, T., Othman, M., Harb, F., Azar, S. T., & Ghadieh, H. E. (2025) · JGH Open · doi:10.1002/jgh3.70315 · Cited by 3 · see citing works

Nutraceutical Strategies for Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): A Path to Liver Health

Vrentzos, E., Pavlidis, G., Korakas, E., Kountouri, A., Pliouta, L., Dimitriadis, G., & Lambadiari, V. (2025) · Nutrients · doi:10.3390/nu17101657 · Cited by 25 · see citing works

Clinical Phenotypes and Personalized Nutritional Strategies in Metabolic Dysfunction-Associated Steatotic Liver Disease

Meashima, C. A. A., Echeverria, G. A. G., Mazón, M. C. M., Hernandez, C. D. C., Rivera, F. A. B., Lucas, C. P., Usuay, S. O. T., & Haro, L. A. E.-D. (2026) · IECCMEXICO · doi:10.64784/341